These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16395719)

  • 1. Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Biotechnol Bioeng; 2006 Mar; 93(4):647-55. PubMed ID: 16395719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Thromb Haemost; 2005 Nov; 94(5):933-41. PubMed ID: 16363233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).
    Fairlie WD; Uboldi AD; Hemmings GJ; Smith BJ; Martin HM; Morgan PO; Baca M
    Biochemistry; 2003 Nov; 42(45):13193-201. PubMed ID: 14609330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
    Lu YA; Felix AM
    Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity.
    Yamamoto Y; Tsutsumi Y; Yoshioka Y; Nishibata T; Kobayashi K; Okamoto T; Mukai Y; Shimizu T; Nakagawa S; Nagata S; Mayumi T
    Nat Biotechnol; 2003 May; 21(5):546-52. PubMed ID: 12665803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
    Shibata H; Yoshioka Y; Ikemizu S; Kobayashi K; Yamamoto Y; Mukai Y; Okamoto T; Taniai M; Kawamura M; Abe Y; Nakagawa S; Hayakawa T; Nagata S; Yamagata Y; Mayumi T; Kamada H; Tsutsumi Y
    Clin Cancer Res; 2004 Dec; 10(24):8293-300. PubMed ID: 15623605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies.
    Kessel C; Kreuz W; Klich K; Becker-Peters K; Vorpahl F; Dietrich U; Klingebiel T; Königs C
    ChemMedChem; 2009 Aug; 4(8):1364-70. PubMed ID: 19533722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of a lysine-deficient LIGHT mutant with the capacity for site-specific PEGylation and low affinity for a decoy receptor.
    Morishige T; Yoshioka Y; Inakura H; Tanabe A; Yao X; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
    Biochem Biophys Res Commun; 2010 Mar; 393(4):888-93. PubMed ID: 20175993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides derived from a secretory yeast library restore factor VIII activity in the presence of an inhibitory antibody.
    Mersich C; Billes W; Pabinger I; Jungbauer A
    Biotechnol Bioeng; 2007 Sep; 98(1):12-21. PubMed ID: 17390380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity.
    Cazalis CS; Haller CA; Sease-Cargo L; Chaikof EL
    Bioconjug Chem; 2004; 15(5):1005-9. PubMed ID: 15366953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of hydrophobic peptides by reversible cysteine PEGylation.
    Pomroy NC; Deber CM
    Biochem Biophys Res Commun; 1998 Apr; 245(2):618-21. PubMed ID: 9571204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of bis- and tris-branched COOH-terminal pegylating reagents: conjugation to NH-terminal peptides.
    Felix AM; Bandaranayake RM
    J Pept Res; 2005 Jan; 65(1):71-6. PubMed ID: 15686537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol).
    Zhang G; Han B; Lin X; Wu X; Yan H
    J Biochem; 2008 Dec; 144(6):781-8. PubMed ID: 18845567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli.
    DeFrees S; Wang ZG; Xing R; Scott AE; Wang J; Zopf D; Gouty DL; Sjoberg ER; Panneerselvam K; Brinkman-Van der Linden EC; Bayer RJ; Tarp MA; Clausen H
    Glycobiology; 2006 Sep; 16(9):833-43. PubMed ID: 16717104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
    Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.